Reach Us +1 218 451 2974
Understanding Of Brain Death Depends On An Advancement Of Technology | 60518
ISSN: 2155-9562

Journal of Neurology & Neurophysiology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Understanding of brain death depends on an advancement of technology

2nd International Conference on Central Nervous System Disorders & Therapeutics

Galymzhan Kuatbay and Tursonjan Tokay

Nazarbayev University, Kazakhstan

Posters & Accepted Abstracts: J Neurol Neurophysiol

DOI: 10.4172/2155-9562.C1.041

Brain death (BD) is the clinical condition of complete loss of brain function and the state of being in an irreversible coma diagnosed by apnea test, testing for brainstem reflexes and other examinations depending on country. There is a consensus among the neuroscientists that the total brain malfunction is considered as the death of the whole body. However, people diagnosed as BD nevertheless retain full homeostasis despite no case of full recovery from that condition documented. What it tells us is that the tests like EEG is not sufficient for BD diagnosis which was eliminated from the BD diagnosis in Commonwealth countries. Even the apnea test is not included as confirmatory for BD diagnosis in some countries and in others it differs in timing. In 1947 when the first defibrillation of heart was implemented the death was “Reversible”. The recent studies on patients in coma show that using optogenetic rehabilitation made it possible for patients in coma to achieve harmonic psychosomatic balance. Recently, Bioquark Inc. and Revita Life Sciences received IRB approval for the first-in-human brain death study where they will implement the use of stem cells and try to “Cure” BD patients. If the study succeeds, we will need other criteria to determine BD as a disease or as the death of the whole body. In this poster presentation, the analysis of BD criteria and diagnosis since 1967 will be discussed, and how it changed and will change over time with the advancement of technology.

Galymzhan Kuatbay has completed his Bachelor at the Nazarbayev University, majoring in Biological Sciences. Currently, he is a 2nd year Medical Student at the Nazarbayev University School of Medicine and his research interest is in the area of brain dysfunctions and the use of optogenetics.

Email: [email protected]

Relevant Topics